Latest & greatest articles for fatigue

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fatigue or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fatigue and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fatigue

201. Management of cancer symptoms: pain, depression, and fatigue

Management of cancer symptoms: pain, depression, and fatigue Management of cancer symptoms: pain, depression, and fatigue Management of cancer symptoms: pain, depression, and fatigue Carr D, Goudas L, Lawrence D, Pirl W, Lau J, DeVine D, Kupelnick B, Miller K Authors' objectives The objective was to determine the prevalence, method of assessment and the effectiveness of treatment for cancer-related pain, depression and fatigue in patients with cancer. This abstract will focus only (...) pharmacological and non-pharmacological cytotoxic or cytostatic therapy. 4. To determine the relative efficacy of current adjuvant physical or psychological treatments. 5. To determine the relative efficacy of current invasive surgical and nonsurgical treatments. 6. To evaluate the effectiveness of treatments for cancer-related pain associated with oral mucositis post-herpetic neuralgia. Searching Separate searches were performed for each area: cancer-related pain, depression and fatigue. For cancer-related

DARE.2002

202. Systematic review and meta-analysis of interventions for postoperative fatigue

Systematic review and meta-analysis of interventions for postoperative fatigue Systematic review and meta-analysis of interventions for postoperative fatigue Systematic review and meta-analysis of interventions for postoperative fatigue Rubin G J, Hotopf M Authors' objectives To assess the impact of different interventions on post-operative fatigue, and to determine whether any of these interventions is effective. Searching Two database searches were made. The first was conducted on MEDLINE (...) , EMBASE, CINAHL, PsycINFO, Science Citation Index (via ISI), Social Sciences Citation Index (via ISI), Index to Scientific and Technical Proceedings (via ISI), ASSIA, PREMEDLINE, the Cochrane Library, HealthSTAR and the Index to Theses. These databases were all searched from their inception to July 2001 for English language papers containing surgery-related MeSH or free-text terms in combination with fatigue-related MeSH of free-text terms. The full strategy used is available from the authors

DARE.2002

203. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions

Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions Servaes P, Verhagen C, Bleijenberg G Authors' objectives To review the literature concerning interventions to reduce fatigue in cancer patients. Searching MEDLINE, Current Contents and PsycLIT were searched from (...) 1980 to July 2001. The search terms combined the words 'cancer' (or 'Hodgkin's' or 'tumor' or 'tumour' or 'malign*' or 'haematolog*') and ('intervention' or 'exercise' or 'psychotherapy' or 'group' or 'counsel*') in the title and the word 'fatigue' in the title, keyword or abstract. Only studies published in English or Dutch were included. Study selection Study designs of evaluations included in the review Controlled intervention studies of adult cancer patients, with a sample size of 15 or greater

DARE.2002

205. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis.

Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. BACKGROUND: Certain infections can trigger chronic fatigue syndromes (CFS) in a minority of people infected, but the reason is unknown. We describe some factors that predict or are associated with prolonged fatigue after infectious mononucleosis and contrast these factors with those that predicted mood disorders after the same infection. METHODS: We prospectively studied a cohort (...) of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-tract infections until 6 months after clinical onset. We sought predictors of both acute and chronic fatigue syndromes and mood disorders from clinical, laboratory, and psychosocial measures. FINDINGS: An empirically defined fatigue syndrome 6 months after onset, which excluded comorbid psychiatric disorders, was most reliably predicted by a positive Monospot test at onset (odds ratio 2.1 [95% CI 1.4-3.3

Lancet2001

206. Defining and managing chronic fatigue syndrome

Defining and managing chronic fatigue syndrome Defining and managing chronic fatigue syndrome Defining and managing chronic fatigue syndrome Agency for Healthcare Research and Quality Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Agency for Healthcare Research and Quality. Defining and managing chronic fatigue syndrome. Rockville (...) : Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 42. 2001 Authors' objectives Objectives of this evidence report are to summarize research evidence regarding the case definitions, prevalence, natural history and therapy of chronic fatigue syndrome (CFS). Authors' conclusions Existing case definitions for CFS appear to characterize a group of people with prolonged fatigue and impaired ability to function. The validity and superiority of any particular case

Health Technology Assessment (HTA) Database.2001

207. Chronic fatigue syndrome - exercise and cognitive behaviour therapies

Chronic fatigue syndrome - exercise and cognitive behaviour therapies Chronic fatigue syndrome - exercise and cognitive behaviour therapies Chronic fatigue syndrome - exercise and cognitive behaviour therapies Bernath V Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bernath V. Chronic fatigue syndrome - exercise and cognitive behaviour therapies. Clayton (...) , Victoria: Centre for Clinical Effectiveness (CCE) 2001: 11 Authors' objectives This aim of this critical appraisal was to assess whether exercise or cognitive behaviour therapies are effective in reducing symptoms of chronic fatigue syndrome in hospitalised patients or patients visiting outpatient clinics. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Cognitive Therapy; Exercise Therapy; Fatigue Syndrome, Chronic Language Published English Country of organisation Australia

Health Technology Assessment (HTA) Database.2001

208. Defining and managing chronic fatigue syndrome

Defining and managing chronic fatigue syndrome Defining and managing chronic fatigue syndrome Defining and managing chronic fatigue syndrome Mulrow C D, Ramirez G, Cornell J E, Allsup K Authors' objectives The review covered four research objectives: (1) to find the existing case definitions of chronic fatigue syndrome (CFS) in adults; (2) what case definitions have been substantiated and/or validated in adults; (3) the prevalence and natural history of CFS in adults; and (4) whether (...) there is evidence to show that particular treatments improve clinical symptoms of CFS when compared to placebo, no therapy, or each other. Only the fourth objective is addressed in this abstract of the review. Searching MEDLINE, the Cochrane Library, PsycINFO (from 1980 to July 2000), EMBASE (from 1988 to 1993 and 1998 to 2000) and the Journal of Chronic Fatigue Syndrome (from 1996 to 2000) were searched using an extensive list of search terms, which were listed in full in the report. In addition, Internet

DARE.2001

209. Chronic fatigue syndrome

Chronic fatigue syndrome Chronic fatigue syndrome Chronic fatigue syndrome Dolors Estrada M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Dolors Estrada M. Chronic fatigue syndrome. Barcelona: Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA). IN01/2001. 2001 Authors' objectives To assess (...) the available evidence on the effectiveness of treatments for chronic fatigue syndrome (CFS). Authors' conclusions Based on evidence from randomised controlled trials, only cognitive behavioural therapy has been shown to benefit (improve) physical function in adults with CFS in ambulatory regimen, and on an individualised basis when compared to routine medical treatment. The lack of studies or the contradictory results in other treatments considered (antiviral, immunological, active agents on the central

Health Technology Assessment (HTA) Database.2001

210. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.

Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. 11265953 2001 03 26 2001 04 12 2015 06 16 0140-6736 357 9259 2001 Mar 17 Lancet (London, England) Lancet Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. 841-7 Cognitive behaviour therapy (CBT) seems a promising treatment for chronic fatigue syndrome (CFS), but the applicability of this treatment outside specialised settings has been questioned (...) . We compared CBT with guided support groups and the natural course in a randomised trial at three centres. Of 476 patients diagnosed with CFS, 278 were eligible and willing to take part. 93 were randomly assigned CBT (administered by 13 therapists recently trained in this technique for CFS), 94 were assigned the support-group approach, and 91 the control natural course. Multidimensional assessments were done at baseline, 8 months, and 14 months. The primary outcome variables were fatigue severity

Lancet2001

211. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. 11179154 2001 02 22 2001 03 22 2014 06 13 0959-8138 322 7283 2001 Feb 17 BMJ (Clinical research ed.) BMJ Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. 387-90 To assess the efficacy of an educational intervention explaining symptoms to encourage graded exercise in patients with chronic fatigue syndrome. Randomised controlled trial (...) . Chronic fatigue clinic and infectious diseases outpatient clinic. 148 consecutively referred patients fulfilling Oxford criteria for chronic fatigue syndrome. Patients randomised to the control group received standardised medical care. Patients randomised to intervention received two individual treatment sessions and two telephone follow up calls, supported by a comprehensive educational pack, describing the role of disrupted physiological regulation in fatigue symptoms and encouraging home based

BMJ2001 Full Text: Link to full Text with Trip Pro

212. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial.

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. 11150109 2001 01 11 2001 01 25 2016 10 17 0098-7484 285 1 2001 Jan 03 JAMA JAMA Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. 52-9 Patients with chronic fatigue syndrome (CFS) are more likely than healthy persons to develop neurally mediated hypotension (NMH) in response to prolonged orthostatic (...) stress. To examine the efficacy of fludrocortisone acetate as monotherapy for adults with both CFS and NMH. Randomized, double-blind, placebo-controlled trial conducted between March 1996 and February 1999. Two tertiary referral centers in the United States. One hundred individuals aged 18 to 50 years who satisfied Centers for Disease Control and Prevention criteria for CFS and had NMH provoked during a 2-stage tilt-table test. Eighty-three subjects had adequate outcome data to assess efficacy

JAMA2001

213. Treatments for fatigue in multiple sclerosis: a rapid and systematic review

Treatments for fatigue in multiple sclerosis: a rapid and systematic review Treatments for fatigue in multiple sclerosis: a rapid and systematic review Treatments for fatigue in multiple sclerosis: a rapid and systematic review Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C Authors' objectives To review evidence of the effects and overall effectiveness of promising interventions in the treatment of fatigue in multiple sclerosis (MS). Searching The authors searched MEDLINE (1966 to December (...) or an alternative intervention were included in the review. Specific interventions included in the review Amantadine and pemoline. Participants included in the review Patients diagnosed with clinically definite multiple sclerosis (MS) without restriction by age, sex, or category of MS. Presence of fatigue at baseline was not a necessary criterion. Clinically definite MS was defined as: two attacks and clinical evidence of two lesions (or paraclinical evidence of the second). Outcomes assessed in the review

DARE.2000

214. Treatments for fatigue in multiple sclerosis: a rapid and systematic review

Treatments for fatigue in multiple sclerosis: a rapid and systematic review Treatments for fatigue in multiple sclerosis: a rapid and systematic review Treatments for fatigue in multiple sclerosis: a rapid and systematic review Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Branas P (...) , Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technology Assessment 2000; 4(27): 1-61 Authors' objectives - To identify current treatments for fatigue in MS and their evidence-base. - To systematically review the evidence for those treatments that have been investigated in more than one rigorous study, in order to determine their effectiveness and cost-effectiveness. Authors' conclusions There is insufficient evidence

Health Technology Assessment (HTA) Database.2000

215. Treatments for fatigue in multiple sclerosis: a rapid and systematic review

Treatments for fatigue in multiple sclerosis: a rapid and systematic review Treatments for fatigue in multiple sclerosis: a rapid and systematic review Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need

NIHR HTA programme2000

216. Cognitive behaviour therapy for adults with chronic fatigue syndrome.

Cognitive behaviour therapy for adults with chronic fatigue syndrome. OBJECTIVES: 1. To systematically review all randomised controlled trials of cognitive-behaviour therapy (CBT) for adults with chronic fatigue syndrome (CFS); 2. To test the hypothesis that CBT is more effective than orthodox medical management or other interventions in adults with CFS. SEARCH STRATEGY: 1. Electronic searching of bibliographic databases, including Medline, PsycLIT, Biological Abstracts, Embase, SIGLE, Index (...) in which - adult patients with CFS; - received CBT or a control intervention, being either orthodox medical management or another intervention; - and whose outcomes were assessed in an appropriate way. CBT could be either type 'A' (encouraging return to 'normal' levels of rest and activity) or type 'B' (encouraging rest and activity which were within levels imposed by the disorder). DATA COLLECTION AND ANALYSIS: The two reviewers worked independently throughout the selection of trials and data

Cochrane2000

217. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. 9989716 1999 02 25 1999 02 25 2015 06 16 0140-6736 353 9151 1999 Feb 06 Lancet (London, England) Lancet Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. 455-8 Reports of mild hypocortisolism in chronic fatigue syndrome led us to postulate that low-dose hydrocortisone therapy may be an effective treatment. In a randomised crossover trial, we screened 218 patients with chronic fatigue (...) . 32 patients met our strict criteria for chronic fatigue syndrome without co-morbid psychiatric disorder. The eligible patients received consecutive treatment with low-dose hydrocortisone (5 mg or 10 mg daily) for 1 month and placebo for 1 month; the order of treatment was randomly assigned. Analysis was by intention to treat. None of the patients dropped out. Compared with the baseline self-reported fatigue scores (mean 25.1 points), the score fell by 7.2 points for patients on hydrocortisone

Lancet1999

218. Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy.

Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. 10437877 1999 08 12 1999 08 12 2015 06 16 0140-6736 354 9176 1999 Jul 31 Lancet (London, England) Lancet Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. 397 A woman with chronic hepatitis C and profound fatigue became symptomfree when treated long-term with ondansetron 4 mg twice daily. Altered central serotoninergic neurotransmission may (...) contribute to fatigue complicating chronic liver disease. Jones E A EA eng Case Reports Clinical Trial Letter Randomized Controlled Trial England Lancet 2985213R 0140-6736 0 Serotonin Antagonists 4AF302ESOS Ondansetron AIM IM Adult Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Fatigue drug therapy Female Hepatitis C, Chronic drug therapy Humans Liver Function Tests Ondansetron administration & dosage adverse effects Serotonin Antagonists administration & dosage adverse

Lancet1999

219. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. 9757853 1998 10 08 1998 10 08 2016 10 17 0098-7484 280 12 1998 Sep 23-30 JAMA JAMA Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. 1061-6 Chronic fatigue syndrome (CFS) is associated with a dysregulated hypothalamic-pituitary adrenal axis and hypocortisolemia. To evaluate the efficacy and safety of low-dose oral hydrocortisone as a treatment for CFS (...) . A randomized, placebo-controlled, double-blind therapeutic trial, conducted between 1992 and 1996. A single-center study in a tertiary care research institution. A total of 56 women and 14 men aged 18 to 55 years who met the 1988 Centers for Disease Control and Prevention case criteria for CFS and who withheld concomitant treatment with other medications. Oral hydrocortisone, 13 mg/m2 of body surface area every morning and 3 mg/m2 every afternoon, or placebo, for approximately 12 weeks. A global

JAMA1998

220. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome.

Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. 9180065 1997 07 14 1997 07 14 2008 11 21 0959-8138 314 7095 1997 Jun 07 BMJ (Clinical research ed.) BMJ Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. 1647-52 To test the efficacy of a graded aerobic exercise programme in the chronic fatigue syndrome. Randomised controlled trial with control treatment crossover after the first follow up examination (...) . Chronic fatigue clinic in a general hospital department of psychiatry. 66 patients with the chronic fatigue syndrome who had neither a psychiatric disorder nor appreciable sleep disturbance. Random allocation to 12 weeks of either graded aerobic exercise or flexibility exercises and relaxation therapy. Patients who completed the flexibility programme were invited to cross over to the exercise programme afterwards. The self rated clinical global impression change score, "very much better" or "much

BMJ1997 Full Text: Link to full Text with Trip Pro